A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously... von MILLER, Kathy D, TRIGO, Jose Manuel, WHEELER, Catherine, BARGE, Alan, ROWBOTTOM, Jacqui, SLEDGE, George, BASELGA, Jose

Volltext

Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice von YEZHELYEV, Maksim V, KOEHL, Gudrun, GUBA, Markus, BRABLETZ, Thomas, JAUCH, Karl-Walter, RYAN, Anderson, BARGE, Alan, GREEN, Tim, FENNELL, Michael, BRUNS, Christiane J

Volltext

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors von LoRusso, Patricia M., Gadgeel, Shirish M., Wozniak, Antoinette, Barge, Alan J., Jones, Helen K., DelProposto, Zachary S., DeLuca, Pamela A., Evelhoch, Jeffrey L., Boerner, Scott A., Wheeler, Catherine

Volltext

Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms von Jain, Aditi, Barge, Alan, Parris, Christopher N

Volltext

Vascular Targeting in Pancreatic Cancer: The Novel Tubulin-Binding Agent ZD6126 Reveals Antitumor Activity in Primary and Metastatic Tumor Models von Kleespies, Axel, Köhl, Gudrun, Friedrich, Michael, Ryan, Anderson J., Barge, Alan, Jauch, Karl-Walter, Bruns, Christiane J.

Volltext

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers von Roohullah, Aflah, Cooper, Adam, Lomax, Anna J., Aung, Jennifer, Barge, Alan, Chow, Lilian, McHale, Mark, Desai, Jayesh, Whittle, James R., Tran, Ben, de Souza, Paul, Horvath, Lisa G.

Volltext

Improving the design of phase II trials of cytostatic anticancer agents von Stone, Andrew, Wheeler, Catherine, Barge, Alan

Volltext

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia von Heil, Gerhard, Hoelzer, Dieter, Sanz, Miguel A., Lechner, Klaus, Liu Yin, John A., Papa, Giuseppe, Noens, Luc, Szer, Jeff, Ganser, Arnold, O'Brien, Caroline, Matcham, James, Barge, Alan

Volltext

Optimizing randomized phase II trials assessing tumor progression von Stone, Andrew, Wheeler, Catherine, Carroll, Kevin, Barge, Alan

Volltext

A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Ad... von Archimbaud, Eric, Ottmann, Oliver G., Yin, John A. Liu, Lechner, Klaus, Dombret, Herve, Sanz, Miguel A., Heil, Gerhard, Fenaux, Pierre, Brugger, Wolfram, Barge, Alan, O’Brien-Ewen, Caroline, Matcham, James, Hoelzer, Dieter

Volltext

Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model von Conrad, Claudius, Ischenko, Ivan, Köhl, Gudrun, Wiegand, Ulrich, Guba, Markus, Yezhelyev, Maksim, Ryan, Anderson J, Barge, Alan, Geissler, Edward K, Wedge, Stephen R, Jauch, Karl-Walter, Bruns, Christiane J

Volltext

Vascular Targeting in Pancreatic Cancer: The Novel Tubulin-Binding Agent ZD6126 Reveals Antitumor Activity in Primary and Metastatic Tumor Models1 von Kleespies, Axel, Köhl, Gudrun, Friedrich, Michael, Ryan, Anderson J, Barge, Alan, Jauch, Karl-Walter, Bruns, Christiane J

Volltext

USE OF ZD6474 COMBINED WITH GEMCITABINE IN THE PREPARATION OF MEDICAMENTS AND AS MEDICAMENTS FOR THE PRODUCTION OF AN ANGIOGENIC AND/OR VASCULAR PERMEABILITY REDUCING EFFECT AND PH... von ALAN BARGE

Volltext bestellen

Farmasøytisk preparat omfattende kinazolin-derivatet ZD6474 kombinert med gemcitabin, sett omfattende samme samt anvendelse av disse for fremstilling av medikament for behandling a... von Barge, Alan

Volltext bestellen

USE OF QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONIZING RADIATION IN TREATMENT OF DISEASE ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASCULAR PERM... von BARGE ALAN

Volltext bestellen

USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASC... von BARGE, ALAN

Volltext bestellen

Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy von BARGE ALAN

Volltext bestellen

KOMBINATIONSPRODUKT BESTEHEND AUS EINEM INHIBITOR DER SRC FAMILIE DER NICHT-REZEPTOR TYROSINKINASEN UND GEMCITABIN ZUR BEHANDLUNG ODER PROPHYLAXE VON PANKREASKREBS von BARGE, ALAN

Volltext bestellen

COMBINATION PRODUCT OF INHIBITOR OF THE SRC FAMILY OF NON-RECEPTOR TYROSINE KINASES AND GEMCITABINE FOR USE IN THE TREATMENT OR PROPHLAXIX OF PANCREATIC CANCER von BARGE, ALAN

Volltext bestellen

Use of the quinazoline derivative ZD6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vasc... von BARGE, ALAN

Volltext bestellen